Clinical Trial Update: Efficacy Study of SIMVASTATIN to Treat Chronic Rhinosinusitis After Failure of Optimal Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating simvastatin for chronic rhinosinusitis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Rhinosinusitis | Phase 2 | Status: TERMINATED